Hair thickening compositions and methods of use

Information

  • Patent Grant
  • 10123966
  • Patent Number
    10,123,966
  • Date Filed
    Monday, May 12, 2014
    10 years ago
  • Date Issued
    Tuesday, November 13, 2018
    5 years ago
Abstract
Provided is a method for increasing hair shaft diameter, the method including applying a hair care composition to a region of the hair, wherein the hair care composition includes from about 0.01% to about 10% of hops, wherein the hops is first extracted in glycerin; and from about 0.1% to about 10% of a rheology modifier.
Description
FIELD OF THE INVENTION

The present invention relates to hair care compositions comprising one or more actives useful for increasing hair diameter and methods of use thereof.


BACKGROUND OF THE INVENTION

Many attributes contribute to the appearance of hair considered to be attractive. For instance, hair with a full and thick appearance is very desirable. In contrast, hair with a thin appearance is not as attractive, and can even lead to a perception that the thin-haired individual is older than their chronological age. Because of the foregoing problems associated with thin hair, many individuals expend great effort and time on grooming, yet still do not attain their desired hairstyle and appearance. This can lead to frustration and/or lack of confidence in his or her appearance. These problems can be experienced by both female and male consumers and at a variety of ages.


In view thereof, there is a need to provide consumers with a hair care composition that includes actives which increase hair diameter and therefore create a fuller and thicker appearance of the hair.


SUMMARY OF THE INVENTION

Provided is a method for increasing hair shaft diameter, the method including applying a hair care composition to a region of the hair, wherein the hair care composition includes from about 0.01% to about 10% of hops, wherein the hops is first extracted in glycerin; and from about 0.1% to about 10% of a rheology modifier.


Also provided is a hair care composition comprising from about 0.01% to about 10% of hops, wherein the hops is first extracted in glycerin; and from about 0.1% to about 10% of a rheology modifier.


These and other features, aspects, and advantages of the present invention will become evident to those skilled in the art from a reading of the present disclosure.







DETAILED DESCRIPTION OF EMBODIMENTS OF THE INVENTION

While the specification concludes with the claims particularly pointing and distinctly claiming the invention, it is believed that embodiments of the present invention will be better understood from the following description. In all embodiments of the present invention, all weight percentages are by weight of the total composition, unless specifically stated otherwise. All ratios are weight ratios, unless specifically stated otherwise. All ranges are inclusive and combinable. The number of significant digits conveys neither limitations on the indicated amounts nor on the accuracy of the measurements. All numerical amounts are understood to be modified by the word “about” unless otherwise specifically indicated. All measurements are understood to be made at 25° C. and at ambient conditions, where “ambient conditions” means conditions under about one atmosphere of pressure and at about 50% relative humidity. All such weights as they pertain to listed ingredients are based on the active level and do not include carriers or by-products that may be included in commercially available materials, unless otherwise specified.


As used herein, the term “hair care compositions” are compositions that are applied to the hair and/or the skin underneath the hair, including compositions used to treat or care for the hair. Products contemplated by the phrase “hair care composition” include, but are not limited to after-shave tonics and lotions, creams, emulsions, foams, hair conditioners (rinse-off and leave-on), hair colorants, hair tonics, liquids, lotions, mousses, propellant lotions, shampoos, shave gels, temporary beard hair dyes, and the like.


“Mammalian hair,” as referenced herein, includes hair on any part of the body of a mammal, and can include but is not limited to facial, cranial, or body hair. For instance, it can include hair on the scalp, head, neck, beard, moustache, eyebrows and sideburns hair.


I. Hair Care Compositions


According to an embodiment of the invention, the hair care composition may include one or more solvents, such as dipropyleneglycol, propylene glycol, butylene glycol, 1,4-butanediol, 3-allyloxy-1,2-propanediol, dipropylene glycol n-butyl ether, 1,2-hexanediol, dimethyl isosorbide, ethanol, 1,3-butanediol, 1,3-propanediol, 2,2′-thiodiethanol, and 1,6-hexanediol, or combinations thereof.


According to yet another embodiment, the hair care composition may further include one or more additional hair growth stimulating agents, such as those disclosed in U.S. Patent Application Publication No. 2010/0120871. Accordingly, non-limiting examples of additional hair growth stimulating agents include indole compounds, xanthine compounds, vitamin B3 compounds, panthenol compounds, and derivatives thereof.


A. Indole Compounds


The hair care compositions can further include an indole compound. As used herein, “indole compound” means one or more indoles, derivatives thereof, mixtures thereof, or salts thereof. Accordingly, the composition may include from about 0.1% to about 10% of the indole compound, from about 0.5% to about 5% of the indole compound, or from about 1% to about 2% of the indole compound, for example, wherein the percentage is a weight percentage based on the total weight of the final hair care composition.


B. Xanthine Compounds


The hair care compositions can further include a xanthine compound. As used herein, “xanthine compound” means one or more xanthines, derivatives thereof, and mixtures thereof. Xanthine compounds that can be useful herein include, but are not limited to, caffeine, xanthine, 1-methylxanthine, theophylline, theobromine, derivatives thereof, and mixtures thereof. Accordingly, the composition may include from about 0.1% to about 10% of the xanthine compound, from about 0.5% to about 5% of the xanthine compound, or from about 1% to about 2% of the xanthine compound, for example, wherein the percentage is a weight percentage based on the total weight of the final hair care composition. For example, the hair care composition may further include about 0.75% of caffeine.


In an embodiment, the amount of xanthine may be decreased to lessen potential white residue the may result from various formulations when the xanthine is present in higher amounts. In an embodiment, the hair care composition may comprise from about 0.01% to about 1% xanthine, alternative from about 0.01% to about 0.75% xanthine, alternatively from about 0.01% to about 0.5% xanthine, alternatively from about 0.01% to about 0.25% xanthine, and alternatively from about 0.01% to about 0.1% xanthine. In an embodiment, the hair care composition may have no xanthine.


C. Vitamin B3 Compounds


The hair care compositions can further include a vitamin B3 compound. As used herein, “vitamin B3 compound” means nicotinic acid, niacinamide, nicotinyl alcohol, derivatives thereof, and mixtures thereof. The vitamin B3 compound may be included as the substantially pure material, or as an extract obtained by suitable physical and/or chemical isolation from natural (e.g., plant) sources. Accordingly, the composition may include from about 0.1% to about 25% of the vitamin B3 compound; from about 0.5% to about 15% of the vitamin B3 compound; or from about 3.5% to about 7.5% of the vitamin B3 compound, for example, wherein the percentage is a weight percentage based on the total weight of the final hair care composition. For example, the hair care composition may further include about 2.5% of vitamin B3.


D. Panthenol Compounds


The hair care compositions can further comprise a panthenol compound. As used herein, the term “panthenol compound” includes panthenol, one or more pantothenic acid derivatives, and mixtures thereof. Non-limiting examples of panthenol compounds include D-panthenol ([R]-2,4-dihydroxy-N-[3-hydroxypropyl)]-3,3-dimethylbutamide), D,L-panthenol, pantothenic acids and their salts (e.g., the calcium salt), panthenyl triacetate, royal jelly, panthetine, pantotheine, panthenyl ethyl ether, pangamic acid, pantoyl lactose, Vitamin B complex, or mixtures thereof. Accordingly, the composition may include from about 0.01% to about 5% of the panthenol compound; from about 0.03% to about 3% of the panthenol compound; from about 0.05% to about 2% of the panthenol compound; or from about 0.1% to about 1% of the panthenol compound, for example, wherein the percentage is a weight percentage based on the total weight of the final hair care composition. For example, the hair care composition may further include about 0.15% of panthenol.


According to another aspect of the present invention, the hair care compositions may be free of oleanolic acid and/or biotinyl-GHK, which is contrary to that described in U.S. Patent Application No. 20060067905.


E. Hops


In an embodiment, the hair care composition may comprise hops. The hair care composition may comprise from about 0.01% about 5% hops, alternatively from about 0.01% to about 3% hops, alternatively from about 0.01% to about 1.5% hops, and alternatively from about 0.01% to about 1% hops. In an embodiment, the hair care composition may comprise no hops.


The hops may be extracted by different methods, including extraction in glycerin, extraction in water and denatured alcohol, or extraction in propylene glycol. In an embodiment, the hops is extracted in glycerin. In an embodiment, the hops extracted in glycerin may provide improved thickening as compared to other extraction methods. In an embodiment, the hops is of the Humulus Lupulus species.


F. Resorcinol


In an embodiment, the hair care composition may comprise resorcinol. The hair care composition may comprise from about 1% to about 14% resorcinol, alternatively from about 1% to about 13% resorcinol, alternatively from about 1% to about 11% resorcinol, alternatively from about 1% to about 9% resorcinol, alternatively from about 1% to about 8% resorcinol, alternatively from about 1% to about 4% resorcinol, and alternatively from about 1% to about 3% resorcinol.


In an embodiment, the resorcinol may be chlorinated. In an embodiment, the resorcinol may be non-chlorinated. In an embodiment, the chlorinated resorcinol may provide improved thickening as compared to non-chlorinated resorcinol.


G. Rheology Modifier


In one embodiment, the composition comprises a rheology modifier to increase the substantivity of the composition. Any suitable rheology modifier can be used. In an embodiment, the hair care composition may comprise from about 0.1% to about 10% of a rheology modifier, alternatively from about 0.5% to about 2.2% of a rheology modifier, alternatively from about 0.7% to about 2% of a rheology modifier, and alternatively from about 1% to about 1.5% of a rheology modifier. In an embodiment, the hair care composition may comprise from about 0.5% to about 2% of a rheology modifier, alternatively from about 0.5% to about 1.9% of a rheology modifier, alternatively from about 0.5% to about 1.7% of a rheology modifier, and alternatively from about 0.5% to about 1.4% of a rheology modifier. In an embodiment, the rheology modifier may be a polyacrylamide thickener.


Non-limiting examples of rheology modifiers include acrylamide/ammonium acrylate copolymer (and)polyisobutene (and) polysorbate 20; acrylamide/sodium acryloyldimethyl taurate copolymer/isohexadecane/polysorbate 80; acrylates copolymer; acrylates/beheneth-25 methacrylate copolymer; acrylates/C10-C30 alkyl acrylate crosspolymer; acrylates/steareth-20 itaconate copolymer; ammonium polyacrylate/Isohexadecane/PEG-40 castor oil; C12-16 alkyl PEG-hydroxypropylhydroxyethyl ethylcellulose (HM-EHEC); carbomer; crosslinked polyvinylpyrrolidone (PVP); dibenzylidene sorbitol; hydroxyethyl ethylcellulose (EHEC); hydroxypropyl methylcellulose (HPMC); hydroxypropyl methylcellulose (HPMC); hydroxypropylcellulose (HPC); methylcellulose (MC); methylhydroxyethyl cellulose (MEHEC); PEG-150/decyl alcohol/SMDI copolymer; PEG-150/stearyl alcohol/SMDI copolymer; polyacrylamide/C13-14 isoparaffin/laureth-7; polyacrylate 13/polyisobutene/polysorbate 20; polyacrylate crosspolymer-6; polyamide-3; polyquaternium-37 (and) hydrogenated polydecene (and) trideceth-6; polyurethane-39; sodium acrylate/acryloyldimethyltaurate/dimethylacrylamide; crosspolymer (and) isohexadecane (and) polysorbate 60; sodium polyacrylate. Exemplary commercially-available rheology modifiers include ACULYN™ 28, Klucel M CS, Klucel H CS, Klucel G CS, SYLVACLEAR AF1900V, SYLVACLEAR PA1200V, Benecel E10M, Benecel K35M, Optasense RMC70, ACULYN™33, ACULYN™46, ACULYN™22, ACULYN™44, Carbopol Ultrez 20, Carbopol Ultrez 21, Carbopol Ultrez 10, Carbopol 1342, Sepigel™ 305, Simulgel™600, Sepimax Zen, and combinations thereof.


H. Carrier


According to another aspect of the present invention, the hair care compositions may further include at least about 20 weight percent of an aqueous carrier. According to one embodiment, the aqueous carrier may be prepared from demineralized or distilled water, for example. Other acceptable carriers that may be used in the aqueous carrier include, but are not limited to alcohol compounds, such as ethanol. According to one embodiment, the composition comprises alcohol, dipropylene glycol, and/or water.


The hair care compositions may have a pH ranging from about 3.0 to about 10, which may be measured by taking a direct pH measurement using a standard hydrogen electrode of the composition at 25° C. Accordingly, the pH of the hair care composition may be within the range from about 6 to about 9, for example.


I. Optional Ingredients


The compositions of the present invention can also additionally comprise any suitable optional ingredients as desired. For example, the composition can optionally include other active or inactive ingredients.


The compositions may include other common hair ingredients such as pyrithione zinc, minoxidil, silicones, glycerin, conditioning agents, and other suitable materials. The CTFA Cosmetic Ingredient Handbook, Tenth Edition (published by the Cosmetic, Toiletry, and Fragrance Association, Inc., Washington, D.C.) (2004) (hereinafter “CTFA”), describes a wide variety of nonlimiting materials that can be added to the composition herein. Examples of these ingredient classes include, but are not limited to: abrasives, absorbents, aesthetic components such as fragrances, pigments, colorings/colorants, essential oils, skin sensates, astringents, etc. (e.g., clove oil, menthol, camphor, eucalyptus oil, eugenol, menthyl lactate, witch hazel distillate), anti-acne agents, anti-caking agents, antifoaming agents, antimicrobial agents (e.g., iodopropyl butylcarbamate), antioxidants, binders, biological additives, buffering agents, bulking agents, chelating agents, chemical additives, colorants, cosmetic astringents, cosmetic biocides, denaturants, drug astringents, external analgesics, film formers or materials, e.g., polymers, for aiding the film-forming properties and substantivity of the composition (e.g., copolymer of eicosene and vinyl pyrrolidone), opacifying agents, pH adjusters, propellants, reducing agents, sequestrants, rheology modifiers, hair conditioning agents, and surfactants.


In one embodiment, the composition comprises a rheology modifier to increase the substantivity of the composition, such that it does not drip undesirably onto other areas of the body, onto clothing, or onto home furnishings and may also perform as a film former. Any suitable rheology modifier can be used, for example, a cellulose-based rheology modifier, such as hydroxypropylmethylcellulose. Other non-limiting examples of rheology modifiers include acrylamide/ammonium acrylate copolymer (and)polyisobutene (and) polysorbate 20; acrylamide/sodium acryloyldimethyl taurate copolymer/isohexadecane/polysorbate 80; acrylates copolymer; acrylates/beheneth-25 methacrylate copolymer; acrylates/C10-C30 alkyl acrylate crosspolymer; acrylates/steareth-20 itaconate copolymer; ammonium polyacrylate/Isohexadecane/PEG-40 castor oil; C12-16 alkyl PEG-2 hydroxypropylhydroxyethyl ethylcellulose (HM-EHEC); carbomer; crosslinked polyvinylpyrrolidone (PVP); dibenzylidene sorbitol; hydroxyethyl ethylcellulose (EHEC); hydroxypropyl methylcellulose (HPMC); hydroxypropyl methylcellulose (HPMC); hydroxypropylcellulose (HPC); methylcellulose (MC); methylhydroxyethyl cellulose (MEHEC); PEG-150/decyl alcohol/SMDI copolymer; PEG-150/stearyl alcohol/SMDI copolymer; polyacrylamide/C13-14 isoparaffin/laureth-7; polyacrylate 13/polyisobutene/polysorbate 20; polyacrylate crosspolymer-6; polyamide-3; polyquaternium-37 (and) hydrogenated polydecene (and) trideceth-6; polyurethane-39; sodium acrylate/acryloyldimethyltaurate/dimethylacrylamide; crosspolymer (and) isohexadecane (and) polysorbate 60; sodium polyacrylate. Exemplary commercially-available rheology modifiers include ACULYN™ 28, Klucel M CS, Klucel H CS, Klucel G CS, SYLVACLEAR AF1900V, SYLVACLEAR PA1200V, Benecel E10M, Benecel K35M, Optasense RMC70, ACULYN™33, ACULYN™46, ACULYN™22, ACULYN™44, Carbopol Ultrez 20, Carbopol Ultrez 21, Carbopol Ultrez 10, Carbopol 1342, Sepigel™ 305, Simulgel™600, Sepimax Zen, and combinations thereof.


The formulations of the present invention may be present in typical hair care compositions. They may be in the form of solutions, dispersion, emulsions, powders, talcs, encapsulated, spheres, spongers, solid dosage forms, foams, and other delivery mechanisms. The composition of the present invention may be hair tonics, leave-on hair products such as conditioners, treatment, and styling products, rinse-off hair products such as conditioners, shampoos, and treatment products; and any other form that may be applied to the hair and preferably applied to the scalp.


II. Method for Increasing Hair Shaft Diameter


The hair care composition described above may also be used in a method for increasing hair shaft diameter. The method may comprise applying the hair care composition to a region of the hair, wherein the hair care composition comprises from about 0.01% to about 10% of hops, wherein the hops is first extracted in glycerin; and from about 0.1% to about 10% of a rheology modifier.


Formulations and Examples

The following are non-limiting examples of the present invention. The examples are given solely for the purpose of illustration and are not to be construed as limitations of the present invention, as many variations thereof are possible without departing from the spirit and scope of the invention, which would be recognized by one of ordinary skill in the art.


Example 1














Component
(wt %)


















Alcohol 100% DEB 100 (Ethanol)
50



Sepigel 305
1.89



Hops
0.90



Fragrance: Watergarden
0.30



Silicone: Abil B 8832
0.30



Deionized water
Qs





*Sepigel ™ 305: Polyacrylamide/C13-14 Isoparaffin/Laureth-7 from Seppic


*Hops: Humulus Lupulus (Hops) Extract 8060-28-4 from Bio-Botanica (extracted in glycerin)






Example 2














Component
(wt %)


















Alcohol 100% DEB 100 (Ethanol)
58



Sepigel 305
1.89



Resorcinol
0.15



Hops
0.9



Caffeine
0.95



Niacinamide
3.15



Panthenol
0.15



Fragrance:
0.6



Amaze XT
0.85



Deionized water
Qs





*Sepigel ™ 305: Polyacrylamide/C13-14 Isoparaffin/Laureth-7 from Seppic


*Resorcinol: 1,3-Dihydroxybenzene from Jos H Lowenstein & Sons Inc.


*Hops: Humulus Lupulus (Hops) Extract 8060-28-4 from Bio-Botanica (extracted in glycerin)


*Amaze XT: dehydroxy xanthan gum from Akzo Nobel






Data












TABLE 1





Hops
Hops
Sepigel
Average Thickness
Viscosity


[%]
Type
[%]
Increase [μm]
[cps]







0.9
1
1.89
7.5
14823


0.9
2
1.89
1.7
11429


0.9
3
1.89
1.4
13352





*Hops 1: Humulus Lupulus (Hops) Extract 8060-28-4 from Bio-Botanica (extracted in glycerin)


*Hops 2: Humulus Lupulus (Hops) Extract 8060-28-4 from IBT (extracted in water and denatured alcohol)


*Hops 3: Humulus Lupulus (Hops) Extract 8060-28-4 from Arch Chemicals, Inc. (extracted in propylene glycol)






The data in Table 1 surprisingly showed that Hops Type 1 provided a measurable average thickness increase of the hair follicle when compared to Hops Type 2 and Type 3. The Example 1 formula was used to formulate each leg, substituting different types of hops.


In the examples, all concentrations are listed as weight percent, unless otherwise specified and may exclude minor materials such as diluents, filler, and so forth. The listed formulations, therefore, comprise the listed components and any minor materials associated with such components. As is apparent to one of ordinary skill in the art, the selection of these minors will vary depending on the physical and chemical characteristics of the particular ingredients selected to make the hair care compositions.


Test Methods

Measurement of Average Thickness Increase






    • 1) Asian or Caucasian hair fibers (low-lift general population) are soaked in deionized water for 10 minutes, and allowed to equilibrate overnight in at Controlled Temperature and Humidity room (20 C, 50 RH).

    • 2) The single hair fibers are imaged with microscope and the diameter is measured using software for baseline measurement.

    • 3) The hair fibers are then treated with the hair care composition for 10 minutes to allow for saturation. The fibers are then removed and allowed to equilibrate and dry overnight.

    • 4) The next day, the fibers are imaged and measured for a final reading. For each experiment, untreated control and product treatment controls are ran, and at least 5 fibers are measured per treatment.

    • 5) In order to measure increase in thickness as a function of treatment, the final diameter is subtracted from the initial diameter. The average thickness increase is reported in the Table above, with measurements reported in micrometers.


      Viscosity Test Method





The hair care composition may have a viscosity of from about 2,000 cps to about 20,000 cps, alternatively from about 10,000 cps to about 15,000 cps. The viscosity of the hair care composition may be determined by a cone and plate viscometer/rheometer which measures the viscous drag resulting from the sample material contained in the gap between a rotating cone and a stationary plate. The geometry of the cone and plate may be such that the entire sample is subjected to a uniform shear rate. A Brookfield Rheometer RS, with Cone C75-1, 26.7° C. temperature, 2.5 mL sample size, at 2 res/sec for 3 minutes may be used.


The dimensions and values disclosed herein are not to be understood as being strictly limited to the exact numerical values recited. Instead, unless otherwise specified, each such dimension is intended to mean both the recited value and a functionally equivalent range surrounding that value. For example, a dimension disclosed as “40 mm” is intended to mean “about 40 mm.”


All documents cited in the Detailed Description of Embodiments of the Invention are, in relevant part, incorporated herein by reference; the citation of any document is not to be construed as an admission that it is prior art with respect to the present invention. To the extent that any meaning or definition of a term in this document conflicts with any meaning or definition of the same term in a document incorporated by reference, the meaning or definition assigned to that term in this document shall govern.


While particular embodiments of the present invention have been illustrated and described, it would be obvious to those skilled in the art that various other changes and modifications can be made without departing from the spirit and scope of the invention. It is therefore intended to cover in the appended claims all such changes and modifications that are within the scope of this invention.

Claims
  • 1. A method for increasing hair shaft diameter, the method comprising applying a hair care composition to a region of the hair, wherein the hair care composition comprises: i. from about 0.01% to 1% of an extract of hops, by weight of the hair care composition; andii. from about 0.5% to about 2.2% of a polyacrylamide thickener, by weight of the hair care composition;iii. at least 20% alcohol, by weight of the composition; wherein the extract of hops consists of a glycerin extract of hops.
  • 2. The method of claim 1, wherein the hair care composition comprises from about 0.7% to about 2% of the polyacrylamide thickener.
  • 3. The method of claim 1, wherein the hair care composition comprises from about 1% to about 1.5% of the polyacrylamide thickener.
  • 4. The method of claim 1, wherein the hair care composition further comprises from about 0.01% to about 5% resorcinol.
  • 5. The method of claim 1, wherein the hair care composition further comprises from about 0.1% to about 10% caffeine.
  • 6. The method of claim 1, wherein the hair care composition further comprises from about 0.1% to about 25% niacinamide.
  • 7. The method of claim 1, wherein the hair care composition further comprises from about 0.01% to about 3% panthenol.
  • 8. The method of claim 4, wherein the resorcinol is chlorinated.
  • 9. The method of claim 1 wherein the hair care composition is a leave-on, liquid hair care composition.
  • 10. A method for increasing hair shaft diameter, the method comprising applying a hair care composition to a region of the hair, wherein the hair care composition comprises: i. from about 0.01% to 1% of an extract of hops, by weight of the hair care composition; andii. from about 0.5% to about 2.2% of a polyacrylamide thickener, by weight of the hair care composition;iii. at least 20% ethanol, by weight of the composition; wherein the extract of hops consists of a glycerin extract of hops;wherein the hops comprise the species Humulus lupulus.
US Referenced Citations (378)
Number Name Date Kind
85311 Kerr et al. Dec 1868 A
665608 Kotz Jan 1901 A
724178 Grant Mar 1903 A
812241 Shubert Feb 1906 A
1064901 Grosert Jun 1913 A
1384671 Murray Jul 1921 A
1431943 Gee Oct 1922 A
1462400 Warren Jul 1923 A
1829021 Sinclair Oct 1931 A
1876033 Starr Sep 1932 A
1956769 Maselli May 1934 A
2031774 Lewis et al. Feb 1936 A
2118566 Miles May 1938 A
2171494 Kyrides Aug 1939 A
2293634 Sluss Aug 1942 A
2381048 Arne Aug 1945 A
2604102 Krause Jul 1952 A
2647490 Twiet Aug 1953 A
2794443 Moore Jun 1957 A
2809971 Bernstein Oct 1957 A
2826551 Geen Mar 1958 A
3101086 Di Vito Aug 1963 A
3204644 Flora Sep 1965 A
3236733 Karsten Feb 1966 A
3295537 Young Jan 1967 A
3457928 Kurshenoff Jul 1969 A
3463170 McCullough Aug 1969 A
3477447 Eldredge Nov 1969 A
3520311 Iesersek et al. Jul 1970 A
3575319 Safianoff Apr 1971 A
3658294 Ewald Apr 1972 A
3730182 Boghosian May 1973 A
3732591 Gach May 1973 A
3753196 Kurtz et al. Aug 1973 A
3755560 Dickert et al. Aug 1973 A
3761418 Parran Sep 1973 A
3960160 Hogan Jun 1976 A
3961635 Miya Jun 1976 A
3964500 Drakoff Jun 1976 A
4090647 Dunning May 1978 A
4121602 Young Oct 1978 A
4144325 Voyt Mar 1979 A
4152416 Spitzer et al. May 1979 A
4209027 Morganroth Jun 1980 A
4273144 Morganroth Jun 1981 A
4288433 Koulbanis et al. Sep 1981 A
4323683 Bolich, Jr. et al. Apr 1982 A
4324553 Bugaut et al. Apr 1982 A
4335103 Barker et al. Jun 1982 A
4345080 Bolick, Jr. Aug 1982 A
4354512 Roppatte, Jr. Oct 1982 A
4364837 Pader Dec 1982 A
4379753 Bolich, Jr. Apr 1983 A
4421769 Dixon et al. Dec 1983 A
4470982 Winkler Sep 1984 A
4495958 Roeder Jan 1985 A
4590687 Caruso May 1986 A
4602651 Roppatte, Jr. Jul 1986 A
4605026 Nolin Aug 1986 A
4671306 Spector Jun 1987 A
4733984 Katsuda et al. Mar 1988 A
4815637 Nellis Mar 1989 A
4872594 Bloom Oct 1989 A
4900545 Wisotzki et al. Feb 1990 A
4901891 Goncalves Feb 1990 A
4934388 Gibbs Jun 1990 A
4983383 Maksimoski et al. Jan 1991 A
5006004 Dirksing et al. Apr 1991 A
5041285 Lundmark Aug 1991 A
5043323 Bombardelli et al. Aug 1991 A
5054504 Winrow Oct 1991 A
5056480 Murray, Sr. Oct 1991 A
5059050 Guglielmo Oct 1991 A
5069898 Goldberg Dec 1991 A
5104646 Bolich, Jr. et al. Apr 1992 A
5106609 Bolich, Jr. et al. Apr 1992 A
5152305 Niv Oct 1992 A
5168833 Spears Dec 1992 A
5215759 Mausner Jun 1993 A
5227164 Lundmark Jul 1993 A
5227503 Hagan et al. Jul 1993 A
5261427 Dolev Nov 1993 A
5270035 Chimento Dec 1993 A
RE34584 Grote et al. Apr 1994 E
5301850 Gueret Apr 1994 A
5307964 Toth May 1994 A
5311887 Ramsey May 1994 A
5337764 McKay Aug 1994 A
5340570 Wong et al. Aug 1994 A
5364885 Ahluwalia et al. Nov 1994 A
5469286 Nicole Nov 1995 A
5470579 Bonte et al. Nov 1995 A
5502056 Breitbarth Mar 1996 A
5514374 Bonte et al. May 1996 A
5520918 Smith May 1996 A
D370783 Korte Jun 1996 S
5523078 Baylin Jun 1996 A
5555899 Foreman Sep 1996 A
5605257 Beard Feb 1997 A
5637606 Matsumoto Jun 1997 A
5641097 Renault et al. Jun 1997 A
5647606 Jordan Jul 1997 A
5649649 Marelli Jul 1997 A
5658575 Ribier et al. Aug 1997 A
5686082 N'Guyen Nov 1997 A
5686367 Hayashi Nov 1997 A
5687884 Bodin et al. Nov 1997 A
5702691 Ichinose et al. Dec 1997 A
D392887 Wadsworth Mar 1998 S
5738250 Gillingham et al. Apr 1998 A
5746348 Bloom May 1998 A
5750122 Evans et al. May 1998 A
5755241 Cheung May 1998 A
5765601 Wells et al. Jun 1998 A
5772077 Tafur Jun 1998 A
5803093 Romano Sep 1998 A
5848598 Walz et al. Dec 1998 A
5876703 Ichinose et al. Mar 1999 A
5937873 Schlosser et al. Aug 1999 A
5939082 Oblong et al. Aug 1999 A
5957342 Gallien Sep 1999 A
5958436 Hahn et al. Sep 1999 A
D415427 Durliat Oct 1999 S
5964226 Sobel Oct 1999 A
5965564 Bianco et al. Oct 1999 A
5975378 Bayer Nov 1999 A
5975381 Revenu Nov 1999 A
D419446 Durliat Jan 2000 S
6013270 Hargraves et al. Jan 2000 A
6013279 Klett-Loch Jan 2000 A
6015549 Cowperthwaite et al. Jan 2000 A
6035806 Lorenzo Mar 2000 A
D424938 Wise May 2000 S
6113926 Soler et al. Sep 2000 A
6120779 Nayak et al. Sep 2000 A
6158617 Hershey et al. Dec 2000 A
6161735 Uchiyama et al. Dec 2000 A
6192047 Oota Feb 2001 B1
6202899 Lasserre et al. Mar 2001 B1
6239170 Ahluwalia et al. May 2001 B1
6260557 Yarbrough Jul 2001 B1
6277360 Carew et al. Aug 2001 B1
6286518 Laporte Sep 2001 B1
6302607 Burrowes et al. Oct 2001 B1
6318595 Walters Nov 2001 B1
6322778 Parr et al. Nov 2001 B1
6325070 Tyroler et al. Dec 2001 B1
6334449 Burrowes et al. Jan 2002 B1
6357449 Chu et al. Mar 2002 B1
6369117 Dubief et al. Apr 2002 B1
6414017 Ahluwalia et al. Jul 2002 B2
6444647 Robinson et al. Sep 2002 B1
6447762 Casado Galcera Sep 2002 B1
6465421 Duranton et al. Oct 2002 B1
D466017 Kuo Nov 2002 S
6495498 Niemiec et al. Dec 2002 B2
6505983 Seo Jan 2003 B1
6526987 Gioia Mar 2003 B1
6539949 Christensen Apr 2003 B2
6570010 Ishida et al. May 2003 B2
6588964 Au et al. Jul 2003 B1
6637440 de Laforcade Oct 2003 B2
6649155 Dunlop et al. Nov 2003 B1
6660047 Stanley, III Dec 2003 B1
6675812 Wiley Jan 2004 B1
6752157 Lu Shao Hua Jun 2004 B2
6766806 Thiebaut Jul 2004 B2
D499966 Arminak Dec 2004 S
6831107 Dederen Dec 2004 B2
6858216 Schulze zur Wiesche et al. Feb 2005 B2
6861061 Maxon et al. Mar 2005 B2
6866167 Bougamont Mar 2005 B2
6877924 Mears et al. Apr 2005 B1
6908889 Niemiec et al. Jun 2005 B2
6962158 Anguelo Nov 2005 B1
6968849 Vena et al. Nov 2005 B2
6976495 Vena et al. Dec 2005 B2
6994846 L'Alloret Feb 2006 B2
7000618 Dovergne et al. Feb 2006 B2
7044137 Glucksman et al. May 2006 B2
7067529 Bolin et al. Jun 2006 B2
7077295 Walker Jul 2006 B2
7081258 Hwang et al. Jul 2006 B2
7081259 Hong Jul 2006 B2
D534425 Kuo Jan 2007 S
7196055 Gilchrest et al. Mar 2007 B2
7234239 Saito et al. Jun 2007 B2
7243660 Capristo Jul 2007 B2
7258852 Maubru Aug 2007 B2
7278590 Greer, Jr. et al. Oct 2007 B1
7285294 Ishino et al. Oct 2007 B2
7294641 Boulle et al. Nov 2007 B2
D574707 Pietrowski et al. Aug 2008 S
7409957 Abergel Aug 2008 B2
7470657 Guillou et al. Dec 2008 B2
7473435 Koganov Jan 2009 B2
7514474 Lipkin et al. Apr 2009 B1
7537791 Koganov May 2009 B2
7550137 Savaide et al. Jun 2009 B2
D605953 Wang Treadway et al. Dec 2009 S
7647933 Morgenstern et al. Jan 2010 B2
7690535 Law et al. Apr 2010 B2
7754775 Mercier et al. Jul 2010 B2
D620807 Wang Treadway et al. Aug 2010 S
7790768 Gan et al. Sep 2010 B2
7798154 De Laforcade Sep 2010 B2
7814917 Hurwitz Oct 2010 B2
7820636 Okuda et al. Oct 2010 B2
7871599 Khoshdel et al. Jan 2011 B2
D636261 Michitsuji et al. Apr 2011 S
7934512 Spagnuolo May 2011 B2
7934626 Choi et al. May 2011 B2
7934667 Westrich May 2011 B2
7972075 Tajima Jul 2011 B2
8047735 Broadley et al. Nov 2011 B2
8109415 Tu Feb 2012 B2
8118036 Wang et al. Feb 2012 B2
8232317 Gan et al. Jul 2012 B2
8316863 De Laforcade et al. Nov 2012 B2
8336558 Hurwitz Dec 2012 B2
8348897 Shih et al. Jan 2013 B2
D675939 Van Gogh Feb 2013 S
D681876 Still May 2013 S
8475510 Simon et al. Jul 2013 B2
D690876 Murdock et al. Oct 2013 S
8637569 Birbara Jan 2014 B2
8784907 Richards et al. Jul 2014 B2
9050407 Shih et al. Jun 2015 B2
9242123 Mahmud et al. Jan 2016 B2
9402792 Mahmud et al. Aug 2016 B2
9554979 Combs et al. Jan 2017 B2
9610233 Mahmud et al. Apr 2017 B2
9649271 Mahmud et al. May 2017 B2
9730953 Birbara Aug 2017 B2
20010003583 Montanari et al. Jun 2001 A1
20010012928 Watabe Aug 2001 A1
20010018920 De Laforcade Sep 2001 A1
20010031281 kung et al. Oct 2001 A1
20010042553 Duqueroie Nov 2001 A1
20020001605 Carew et al. Jan 2002 A1
20020020421 Vayrette Feb 2002 A1
20020034485 Noser et al. Mar 2002 A1
20020056733 Lasserre May 2002 A1
20020114770 Bradley et al. Aug 2002 A1
20020139383 Christensen Oct 2002 A1
20020158084 Herring et al. Oct 2002 A1
20020183297 Niazi Dec 2002 A1
20020197289 Chevalier et al. Dec 2002 A1
20030003073 Muller Jan 2003 A1
20030039619 Bunger et al. Feb 2003 A1
20030049212 Robinson et al. Mar 2003 A1
20030050201 Guillou et al. Mar 2003 A1
20030059392 L'Alloret Mar 2003 A1
20030068297 Jain Apr 2003 A1
20030069618 Smith, III et al. Apr 2003 A1
20030091521 Midha et al. May 2003 A1
20030108577 Lorant et al. Jun 2003 A1
20030108578 Maubru Jun 2003 A1
20030157088 Elliott et al. Aug 2003 A1
20030168476 Sanchez Sep 2003 A1
20030175232 Elliott et al. Sep 2003 A1
20030219392 Kung et al. Nov 2003 A1
20040076654 Vinson et al. Apr 2004 A1
20040131573 Tang Jul 2004 A1
20040141935 Styczynski et al. Jul 2004 A1
20040159326 Fagerstrom et al. Aug 2004 A1
20040171693 Gan et al. Sep 2004 A1
20040175347 Bissett Sep 2004 A1
20040213859 Zelickson Oct 2004 A1
20040214215 Yu et al. Oct 2004 A1
20040223935 Meunier Nov 2004 A1
20040241114 Gupta Dec 2004 A1
20050000535 Kim Jan 2005 A1
20050003024 Oblong et al. Jan 2005 A1
20050031572 Gallinat et al. Feb 2005 A1
20050053561 Suginaka Mar 2005 A1
20050082315 Hayakawa et al. Apr 2005 A1
20050092340 Rijskamp May 2005 A1
20050100525 Taguchi et al. May 2005 A1
20050153003 Menon et al. Jul 2005 A1
20050186290 Cals-Grierson Aug 2005 A1
20050191370 De La Charriere et al. Sep 2005 A1
20050196418 Yu et al. Sep 2005 A1
20050255059 Oblong et al. Nov 2005 A1
20050255060 Oblong et al. Nov 2005 A1
20050271692 Gervasio-Nugent et al. Dec 2005 A1
20060008436 Boulle et al. Jan 2006 A1
20060021628 Mu et al. Feb 2006 A1
20060021629 Mu et al. Feb 2006 A1
20060039878 Khoshdel et al. Feb 2006 A1
20060045926 Nimni et al. Mar 2006 A1
20060054178 Sim Mar 2006 A1
20060067905 Lintner et al. Mar 2006 A1
20060088478 Andrews et al. Apr 2006 A1
20060088492 Goddinger et al. Apr 2006 A1
20060099167 Staudigel et al. May 2006 A1
20060133997 Querleux et al. Jun 2006 A1
20060134053 L'Alloret Jun 2006 A1
20060151539 Tsubaki et al. Jul 2006 A1
20060266774 Hierzer Nov 2006 A1
20060275237 Bissett et al. Dec 2006 A1
20060275245 Decoster et al. Dec 2006 A1
20070003509 Farwick et al. Jan 2007 A1
20070009474 Xie et al. Jan 2007 A1
20070068544 Hackl et al. Mar 2007 A1
20070080172 Tyrrell et al. Apr 2007 A1
20070095360 Meinert et al. May 2007 A1
20070095721 Davis et al. May 2007 A1
20070137669 Hamilton et al. Jun 2007 A1
20070148102 Kalbfleisch et al. Jun 2007 A1
20070160547 Duffy et al. Jul 2007 A1
20070175491 Graefe et al. Aug 2007 A1
20070183993 Binder et al. Aug 2007 A1
20070193597 Hurwitz Aug 2007 A1
20070299032 Ehama et al. Dec 2007 A1
20080020004 Birkel et al. Jan 2008 A1
20080041749 McDermott Feb 2008 A1
20080057015 Oblong et al. Mar 2008 A1
20080059313 Oblong Mar 2008 A1
20080060665 Umeno et al. Mar 2008 A1
20080064723 Ideta et al. Mar 2008 A1
20080115796 Montanari et al. May 2008 A1
20080206156 Cronk Aug 2008 A1
20080206355 Schwartz et al. Aug 2008 A1
20080207560 Harada et al. Aug 2008 A1
20080213198 Lintner et al. Sep 2008 A1
20080245380 Ecker et al. Oct 2008 A1
20080245824 Lyles Oct 2008 A1
20080249073 Farwick et al. Oct 2008 A1
20080254055 Oblong et al. Oct 2008 A1
20080317698 Wells et al. Dec 2008 A1
20090000634 Graefe et al. Jan 2009 A1
20090016970 Cronk Jan 2009 A1
20090017147 Lintner et al. Jan 2009 A1
20090039083 Stull, Sr. et al. Feb 2009 A1
20090108023 Houghton et al. Apr 2009 A1
20090208424 Maibach et al. Aug 2009 A1
20090218418 Sharief Sep 2009 A1
20090220445 Iwata et al. Sep 2009 A1
20090220448 Iwata et al. Sep 2009 A1
20090222350 Iwata et al. Sep 2009 A1
20090264449 Iwata Oct 2009 A1
20090274642 Dawson, Jr. et al. Nov 2009 A1
20090275970 Leibowitz Nov 2009 A1
20100012141 Middlebrook Jan 2010 A1
20100018920 Curran et al. Jan 2010 A1
20100083977 Goddard-Clark et al. Apr 2010 A1
20100120871 Dawson, Jr. et al. May 2010 A1
20100126522 Fujinuma et al. May 2010 A1
20100137238 Gan et al. Jun 2010 A1
20100161029 Filippini et al. Jun 2010 A1
20100170917 Ki Jul 2010 A1
20100218626 Love et al. Sep 2010 A1
20100313905 Fujinuma et al. Dec 2010 A1
20110005538 Mercier et al. Jan 2011 A1
20110041863 Roualdes Feb 2011 A1
20110064511 Pires et al. Mar 2011 A1
20110110872 Koganov et al. May 2011 A1
20110127293 Pascatore Jun 2011 A1
20110232664 Schreiber Sep 2011 A1
20110265805 Laplante Nov 2011 A1
20120034173 Batt et al. Feb 2012 A1
20120058060 Noor et al. Mar 2012 A1
20120097180 Harris et al. Apr 2012 A1
20120152270 Hazan Jun 2012 A1
20120157478 Dawson, Jr. et al. Jun 2012 A1
20120213842 Birbara Aug 2012 A1
20120258185 Oblong et al. Oct 2012 A1
20130133678 Nakashima May 2013 A1
20130164390 Dawson Jun 2013 A1
20130284195 Murdock Oct 2013 A1
20130284196 Murdock Oct 2013 A1
20130309332 Fournial et al. Nov 2013 A1
20140093466 Combs Apr 2014 A1
20140341832 Mahmud et al. Nov 2014 A1
20140371690 Sprada et al. Dec 2014 A1
20150314064 Shih et al. Nov 2015 A1
20170296668 Birbara Oct 2017 A1
Foreign Referenced Citations (120)
Number Date Country
8802728 Aug 2010 BR
0944695 Apr 1974 CA
201261001 Jun 2009 CN
1914822 Jul 1980 DE
4121544 Jan 1993 DE
19824454 Dec 1999 DE
10128799 Jan 2003 DE
10133196 Jan 2003 DE
10140650 Feb 2003 DE
10226468 Jan 2004 DE
10319227 Jun 2004 DE
102004039729 Mar 2006 DE
102004041588 Mar 2006 DE
202006002355 Apr 2006 DE
20023828 Aug 2006 DE
3259969 Apr 1993 EP
0640333 Jan 1995 EP
0943260 Sep 1999 EP
1024091 Aug 2000 EP
1097695 Sep 2002 EP
1161934 Apr 2004 EP
1430933 Jun 2004 EP
1506767 Feb 2005 EP
1308169 Jun 2005 EP
1685826 Aug 2006 EP
1700617 Sep 2006 EP
1709956 Oct 2006 EP
1771144 Jul 2009 EP
1642565 Jul 2010 EP
1676783 Nov 2010 EP
2642941 Feb 1981 FR
2580601 Oct 1986 FR
2643375 Jun 1991 FR
2751541 Oct 1998 FR
2832062 Feb 2004 FR
2930461 Dec 2011 FR
849433 Sep 1960 GB
2174356 Nov 1986 GB
S6168406 Apr 1986 JP
6117945 Aug 1986 JP
63301810 Dec 1988 JP
63310813 Dec 1988 JP
H04189365 Jul 1992 JP
H04193821 Jul 1992 JP
H0597631 Apr 1993 JP
H06211632 Aug 1994 JP
H06234628 Aug 1994 JP
H08040835 Feb 1996 JP
H08073322 Mar 1996 JP
2557390 Nov 1996 JP
08291018 Nov 1996 JP
10203924 Jan 1997 JP
2583812 Feb 1997 JP
09263534 Oct 1997 JP
10053527 Feb 1998 JP
10229978 Sep 1998 JP
H1027439 Oct 1998 JP
H10279437 Oct 1998 JP
H1118821 Jan 1999 JP
11130085 May 1999 JP
H11130085 May 1999 JP
11152213 Jun 1999 JP
2000086449 Mar 2000 JP
2000086510 Mar 2000 JP
3078179 Aug 2000 JP
2001058928 Mar 2001 JP
2001145514 May 2001 JP
3219881 Oct 2001 JP
2001288043 Oct 2001 JP
2002013569 Jan 2002 JP
2002322094 Nov 2002 JP
2002332218 Nov 2002 JP
3400122 Apr 2003 JP
3426436 Jul 2003 JP
2004002264 Jan 2004 JP
2004026709 Jan 2004 JP
2004067573 Mar 2004 JP
2004091354 Mar 2004 JP
2004091370 Mar 2004 JP
2004115465 Apr 2004 JP
2004189644 Jul 2004 JP
2004189645 Jul 2004 JP
4133740 May 2005 JP
2005225849 Aug 2005 JP
2005272394 Oct 2005 JP
2005296352 Oct 2005 JP
3784472 Jun 2006 JP
2006160608 Jun 2006 JP
3820800 Sep 2006 JP
2006232820 Sep 2006 JP
3922311 May 2007 JP
4173667 Oct 2008 JP
2008230619 Oct 2008 JP
4305756 Jul 2009 JP
4469617 May 2010 JP
4554805 Sep 2010 JP
4574384 Nov 2010 JP
5044069 Oct 2012 JP
5483414 May 2014 JP
5872752 Mar 2016 JP
1606121 Nov 1990 SU
WO8804931 Jul 1988 WO
WO8910114 Nov 1989 WO
WO9007290 Jul 1990 WO
WO94014404 Jul 1994 WO
WO9534271 Dec 1995 WO
WO9606686 Mar 1996 WO
WO9911224 Mar 1999 WO
WO0048559 Aug 2000 WO
WO0147482 Jul 2001 WO
WO2006000257 Jan 2006 WO
WO2006027279 Mar 2006 WO
WO2006125442 Nov 2006 WO
WO2007010478 Jan 2007 WO
WO2008104655 Sep 2008 WO
WO 2009090213 Nov 2009 WO
WO2010138266 Dec 2010 WO
WO2011073898 Jun 2011 WO
WO2011156311 Dec 2011 WO
WO2012038334 Mar 2012 WO
Non-Patent Literature Citations (40)
Entry
PCT International Search Report and Written Opinion for PCT/US2014/037617 dated Oct. 6, 2014, 12 pages.
“The treatment of 11 alopecia patients with resorcinol solution”, Japan, Dec. 31, 1975.
“Effects of Zinc on the New Preparation Method of Hydroxy Double Salts”, Inorg. Chem. 1999, 38, 4211-4216.
“Hair care composition and method for increasing diameter of hairs”, Frangrance Journal, Feb. 1992, p. 100.
All final and non-final office actions for U.S. Appl. No. 11/897,084 (P&G Case 10557MC), See Pair.
All final and non-final office actions for U.S. Appl. No. 12/393,311 (P&G Case AA752M), See Pair.
All final and non-final office actions for U.S. Appl. No. 13/527,376 (P&G Case 10557M), See Pair.
All final and non-final office actions for U.S. Appl. No. 13/633,623 (P&G Case 12268), See Pair.
All final and non-final office actions for U.S. Appl. No. 13/723,865 (P&G Case 12319), See Pair.
All final and non-final office actions for U.S. Appl. No. 13/871,123 (P&G Case 12457M), See Pair.
All final and non-final office actions for U.S. Appl. No. 13/871,231 (P&G Case 12458), See Pair.
All final and non-final office actions for U.S. Appl. No. 14/275,100 (P&G Case 12899), See Pair.
All final and non-final office actions for U.S. Appl. No. 14/275,225 (P&G Case 12901), See Pair.
All final and non-final office actions for U.S. Appl. No. 14/275,252 (P&G Case 12902), See Pair.
All final and non-final office actions for U.S. Appl. No. 14/825,643 (P&G Case 12268D), See Pair.
All final and non-final office actions for U.S. Appl. No. 15/195,063 (P&G Case 12899D), See Pair.
All final and non-final office actions for U.S. Appl. No. 29/419,431 (P&G Case D2009), See Pair.
All final and non-final office actions for U.S. Appl. No. 29/447,858 (P&G Case D2009D), See Pair.
Anonymous: Plantur 39 Caffeine Tonic 200ml, XP002534819, Jul. 26, 2008, URL:http://www.askshop.co.uk/shopping/plantur-39-caffeine-tonic-200ml.html.
Berger, R.S., et al., “The effects of minoxidil, 1% pyrithione zinc and a combination of both on hair density: a randomized controlled trial.” British Journal of Dermatology, 2003, 149, pp. 354-362.
Courtois, M. et al., “Aging and hair cycles,” British Journal of Dermatology, 1995, 132, pp. 86-93.
de Lacharriere, O. et al., “Hair Diameter Diversity,” Arch Dematol., 2001, 137, pp. 641-646.
Definition of “denatured alcohol”, http://worldnetweb.princeton.edu/peri/webwn?s=denatured%20alcohol, accessed Mar. 8, 2011.
Factors influencing the skin pH, Aus: pH and Skin Care, www.abw.verlag.de, 2007, pp. 45-49.
Final Report on the Safety Assessment of 4-Chloroesorincol, International Journal of Toxicology, Aug. 1996, pp. 284-294.
Gottschalck, T.E., et al., “International Cosmetic Ingredient Dictionary and Handbook,” 2004, The Cosmetic, Toiletry and Fragrance Association, Washington, D.C., XP002534910, ISBN 1-882621-34-4, 10th ed., vol. 2, p. 1307, col. 1.
Hoffmann, R., “Trichoscan: Combining epiluminescence microscopy with digital image analysis for the measurement of hair growth in vivo,” Eur J. Drmatol 2001; 11, pp. 362-368.
Lacarrubba, F. et al., “Videodermatoscopy Enhances Diagnostic Capability in Some Forms of Hair Loss,” Am J. Clin Dermatol, 2004, 5(3), pp. 205-208.
M.P. Birch et al., “Hair density, hair diameter and the prevalence of female pattern loss,” British Journal of Dermatology 2001; 144, pp. 297-304.
Olsen, EA et al., “Evaluation and treatment of male and female pattern hair loss,” J. Am Acad Dermatol, vol. 52, No. 2, Feb. 2005, p. 301-311.
PCT International Search Report and Written Opinion for PCT/IB2009/050759 dated Feb. 25, 2009.
PCT International Search Report and Written Opinion for PCT/IB2009/050760 dated Aug. 5, 2009.
PCT International Search Report and Written Opinion for PCT/IB2009/050761 dated Feb. 25, 2009.
PCT International Search Report and Written Opinion for PCT/IB2009/050762 dated Feb. 25, 2009.
PCT International Search Report and Written Opinion for PCT/US2012/058560 dated Mar. 11, 2013.
PCT International Search Report and Written Opinion for PCT/US2013/038311 dated Jul. 12, 2013.
PCT International Search Report and Written Opinion for PCT/US2013/038312 dated Jul. 12, 2013.
PCT Invitation to pay additional fees for PCT/US2007/019180 dated May 3, 2008.
The Clinical Report Lansium Domesticum Jack V. Doku, vol. 23, No. 13, p. 133-146 (1989).
W. Wenner, “The Reaction of L-Ascorbic and D-Iosascorbic Acid with Nicotinic Acid and Its Amide,” J. Organic Chemistry, vol. 14, pp. 22-26 (1949).
Related Publications (1)
Number Date Country
20140341832 A1 Nov 2014 US
Provisional Applications (1)
Number Date Country
61824196 May 2013 US